Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
Cantor Fitzgerald
Deloitte
US Department of Justice
Dow
AstraZeneca
Healthtrust
Harvard Business School

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,023,082

« Back to Dashboard

Summary for Patent: 5,023,082
Title: Sustained-release pharmaceutical compositions
Abstract:The present invention pertains to biodegradable sustained-release composins capable of achieving the sustained release of a pharmaceutical or other agent. The compositions can be formed into implant devices which may be used to treat a wide variety of diseases and conditions. The implants are especially useful in treating diseases such as periodontal disease which require prolonged drug release.
Inventor(s): Friedman; Michael (Jerusalem, IL), Steinberg; Doron (Jerusalem, IL), Soskolne; Aubrey (Jerusalem, IL)
Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)
Application Number:07/175,623
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,023,082
Patent Claim Types:
see list of patent claims
Composition; Use; Device;

Drugs Protected by US Patent 5,023,082

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,023,082

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel78826May 18, 1986

International Family Members for US Patent 5,023,082

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 80996 ➤ Try a Free Trial
Australia 605487 ➤ Try a Free Trial
Australia 7480687 ➤ Try a Free Trial
Canada 1307463 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Deloitte
Dow
McKesson
Mallinckrodt
QuintilesIMS
Johnson and Johnson
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.